KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) Net Margin (2016 - 2025)

Zimmer Biomet Holdings has reported Net Margin over the past 17 years, most recently at 6.15% for Q4 2025.

  • Quarterly results put Net Margin at 6.15% for Q4 2025, down 336.0% from a year ago — trailing twelve months through Dec 2025 was 8.56% (down 260.0% YoY), and the annual figure for FY2025 was 8.57%, changed.
  • Net Margin for Q4 2025 was 6.15% at Zimmer Biomet Holdings, down from 11.55% in the prior quarter.
  • Over the last five years, Net Margin for ZBH hit a ceiling of 21.63% in Q4 2023 and a floor of 3.54% in Q1 2022.
  • Median Net Margin over the past 5 years was 9.28% (2023), compared with a mean of 7.55%.
  • Peak annual rise in Net Margin hit 2883bps in 2021, while the deepest fall reached -3947bps in 2021.
  • Zimmer Biomet Holdings' Net Margin stood at 1.64% in 2021, then plummeted by -115bps to 3.54% in 2022, then surged by 712bps to 21.63% in 2023, then tumbled by -56bps to 9.51% in 2024, then tumbled by -35bps to 6.15% in 2025.
  • The last three reported values for Net Margin were 6.15% (Q4 2025), 11.55% (Q3 2025), and 7.38% (Q2 2025) per Business Quant data.